Clinical Outcomes, Costs, and Healthcare Resource Utilization in Patients with Metastatic Merkel Cell Carcinoma Treated with Immune Checkpoint Inhibitors vs Chemotherapy.

Clinicoecon Outcomes Res · 2021 · PMC8001053 · PMID 33790597

Europe PMC DOI

hedged sentences

—

closest p

—

boldest claim

The sentences

failed to reach statistical significanceno p-value reported

Although this difference failed to reach statistical significance in our small sample size, the magnitude (a twofold higher persistence for ICI-treated patients) suggests a clinical difference.

also in 6,035 other papers

did not reach statistical significanceno p-value reported

Among patients with inpatient admissions during 180-day follow-up, LOS was approximately 2 days shorter for patients receiving ICIs than for those receiving chemotherapy, although the difference did not reach statistical significance.

also in 111,027 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.